Effect of the common -866GA polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese taiwanese population

Molecular Diagnosis and Therapy

Volumn 14, Issue 2, 2010, Pages 101-106

  Hsiao, Tun Jen ^a   Wu, Lawrence Shih Hsin ^b,c   Hwang, Yuchi ^b   Huang, Shih Yi ^a   Lin, Eugene ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b VITA GENOMICS INC   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Clinical genetics; General; Genetic polymorphism; Genotyping; Obesity; Pharmacogenetics; Sibutramine; Weight loss

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN BETA POLYPEPTIDE 3; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; PLACEBO; SIBUTRAMINE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; CYCLOBUTANE DERIVATIVE; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WEIGHT REDUCTION; ADIPOSE TISSUE; DEMOGRAPHY; GENETICS;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CYCLOBUTANES; DEMOGRAPHY; FEMALE; HUMANS; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; WEIGHT LOSS;

EID: 77950544389     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.2165/11532940-000000000-00000     Document Type: Article

References (26)

1. Sharma B, Henderson DC. Sibutramine: current status as an anti-obesity drug and its future perspectives. Expert Opin Pharmacother 2008; 9 (12): 2161-2173
2. Grudell AB, Sweetser S, Camilleri M, et al. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology 2008; 135 (4): 1142-1154
3. HaunerH,Meier M, Jö ckel KH, et al. Prediction of successfulweight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003; 13 (8): 453-459
4. Hsiao DJ,Wu LS, Huang SY, et al. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenet Genomics 2009; 19 (9): 730-733
5. Vazquez Roque MI, Camilleri M, Clark MM, et al. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol 2007; 5 (7): 829-837 (Pubitemid 47031061)
6. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 2001; 44 (8): 946-965 (Pubitemid 32778126)
7. Yoon Y, Park BL, Cha MH, et al. Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochem Biophys Res Commun 2007; 359 (3): 451-456 (Pubitemid 46908798)
8. Esterbauer H, Schneitler C, Oberkofler H, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middleaged humans. Nat Genet 2001; 28 (2): 178-183 (Pubitemid 32538066)
9. Krempler F, Esterbauer H, Weitgasser R, et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002; 51 (11): 3331-3335 (Pubitemid 35246982)
10. Jun HS, Kim IK, Lee HJ, et al. Effects of UCP2 and UCP3 variants on the manifestation of overweight in Korean children. Obesity (Silver Spring) 2009; 17 (2): 355-362
11. Kovacs P, Ma L, Hanson RL, et al. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia 2005; 48 (11): 2292-2295 (Pubitemid 41618920)
12. D'Adamo M, Perego L, Cardellini M, et al. The-866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 2004; 53 (7): 1905-1910 (Pubitemid 38857052)
13. Wang H, Chu WS, Lu T, et al. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion.AmJ Physiol Endocrinol Metab 2004; 286 (1): E1-7 (Pubitemid 38036602)
14. Bulotta A, Ludovico O, Coco A, et al. The common-866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J Clin Endocrinol Metab 2005; 90 (2): 1176-1180 (Pubitemid 40279251)
15. Bell JT, Wallace C,DobsonR, et al.Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum Mol Genet 2006; 15 (18): 1365-1374
16. Carlborg O, Haley CS. Epistasis: too often neglected in complex trait studies. Nat Rev Genet 2004; 5 (8): 618-625 (Pubitemid 39005756)
17. Lin E, Hwang Y, Liang KH, et al. Pattern-recognition techniques with haplotype analysis in pharmacogenomics. Pharmacogenomics 2007; 8 (1): 75-83 (Pubitemid 46157759)
18. Lin E, Hwang Y, Chen EY. Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C. Pharmacogenomics 2007; 8 (10): 1327-1335 (Pubitemid 350167101)
19. Lin E, Hsu SY. A Bayesian approach to gene-gene and gene-environment interactions in chronic fatigue syndrome. Pharmacogenomics 2009; 10 (1): 35-42
20. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27 (5): 1182-1186 (Pubitemid 38579787)
21. Lin E, Pei D, Huang YJ, et al. Gene-gene interactions among genetic variants from obesity candidate genes for nonobese and obese populations in type 2 diabetes. Genet Test Mol Biomarkers 2009; 13 (4): 485-493
22. Wu LS, Hsieh CH, Pei D, et al. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 2009 Nov; 24 (11): 3360-3366
23. Sesti G, Cardellini M, Marini MA, et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucosetolerant subjects. Diabetes 2003; 52 (5): 1280-1283 (Pubitemid 36523369)
24. Getty L, Hamilton-Wessler M, Ader M, et al. Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Diabetes 1998; 47 (12): 1941-1947 (Pubitemid 28549203)
25. Lin E, Chen PS, Chang HH, et al. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33 (7): 1167-1172
26. Huang LC, Hsu SY, LinE.Acomparison of classificationmethods for predicting chronic fatigue syndrome based on genetic data. J Transl Med 2009; 7 (1): 81